Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Teladoc Health Narrows FY2025 GAAP EPS Guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) Est; Narrows FY2025 Sales Guidance from $2.501B-$2.548B to $2.510B-$2.539B vs $2.522B Est

Author: Benzinga Newsdesk | October 29, 2025 03:09pm
Teladoc Health (NYSE:TDOC) narrows FY2025 GAAP EPS guidance from $(1.35)-$(1.00) to $(1.25)-$(1.10) vs $(1.12) analyst estimate. Narrows FY2025 sales outlook from $2.501 billion-$2.548 billion to $2.510 billion-$2.539 billion vs $2.522 billion estimate.

Posted In: TDOC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist